JoVE Logo

Zaloguj się

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

6.3K Views

07:24 min

December 13th, 2018

DOI :

10.3791/58598-v

December 13th, 2018


Przeglądaj więcej filmów

Multiple Myeloma

Rozdziały w tym wideo

0:04

Title

0:56

Synthesis of Functionalized SWCNTs

1:53

Conjugation of Anti-MALAT1 Gapmer DNA Flanked by 2'-O Modified RNAs to Functionalized SWCNT

2:54

Tail Vein Injection of SWCNT-anti-MALAT1

4:14

Evaluation of the Disease Progression

5:01

Results: SWCNT-anti-MALAT1 Oligonucleotides Successfully Represses Multiple Myeloma Cell Growth

6:51

Conclusion

Powiązane Filmy

article

06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

7.6K Views

article

05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

6.7K Views

article

12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

7.3K Views

article

00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

7.2K Views

article

11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

7.5K Views

article

07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

2.4K Views

article

10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

13.1K Views

article

Antisense Oligonucleotides as a Tool for Prolonged Knockdown of Nuclear lncRNAs in Human Cell Lines

487 Views

article

09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

300 Views

article

10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

13.0K Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone